Should FDA Accelerated Approval Pathway for ST-920 Gene Therapy Data Require Action From Sangamo Therapeutics (SGMO) Investors?

Sangamo Therapeutics recently reported detailed data from its completed registrational Phase 1/2 STAAR study of isaralgagene ...
Seeking Alpha

Ikena: AACR2023 Validates Their Hippo Pathway Target, But We Need Data

Lead asset is a TEAD1 inhibitor IK-930 targeting the HIPPO pathway. It works through disruption of the link between transcriptional enhancer activator domain (TEAD') and its co-activator ...
Seeking Alpha

Vigil Neuroscience: Interim Data Sheds Light On Possible Accelerated Pathway

Vigil Neuroscience (VIGL) has made great progress in being able to advance its pipeline. It just reported interim results from its phase 2 IGNITE study, which used its drug iluzanebart [formerly ...
Business Wire

Syntellis Launches Focus Pathway: A Claims Visualization Solution That Transforms Healthcare Data into Actionable Intelligence

CHICAGO--(BUSINESS WIRE)--Syntellis Performance Solutions, the leading provider of enterprise performance management software, data and intelligence solutions, today announced the launch of Focus ...
GEN

Systems Biology Tools for Integrated Omics Analysis

Advancements in next-generation sequencing (NGS) technologies have enabled researchers to generate genome-wide data of unprecedented quality and quantity. Genomics, expression, microRNA, chromatin IP, ...